net profit ended 30 September 2017 which increased by Baht 150 million or 6%, compared with the same period in the previous year with the details as follows: I. Revenues from operations by business
of Thailand PACE Development Corporation Public Company Limited (“the Company”) would like to report the operating results for the third quarter of the year 2017 ended 30 September 2017 (Q3 2017). The
, Amohoe Pluag-daeng, Rayong Branch 2 / 38 Moo. Tambon Tarsit, Amohoe Pluag-daeng, Rayong 1 KWM 002/2562 February 27th, 2019 Subject : Management Discussion and Analysis for the year ended December 31, 2018
consider and approve financial statement of the company for the fiscal year ended December 31, 2018. 8.4 To consider and approve the allocation of net profit for legal reserve, and dividend payment for the
Company’s Audited Financial Statements for the year 2018 ended 31 December 2018, which has been audited by the auditor, and propose to the Annual General Meeting of Shareholders (“AGM”) to consider and
Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book
Calculating Basis, calculated from the consolidated financial statements ended March 31, 2019 which is categorized into transaction type 2 according to the Notification of the Transaction Regarding the
No. CAZ 015-2019 13 August 2019 Subject: Management Discussion and Analysis 2nd Quarter ended 30 June 2019 Attention: The President The Stock Exchange of Thailand CAZ (Thailand) Public Company
วันที่ 25 กุมภาพันธ์ 2558 August 14, 2019 Subject: Management’s Explanation and Analysis for the 3 months and 6 months period ended June 30, 2019 Attention: Director and Manager The Stock Exchange of